601 E 15th Street, Austin, TX, 78701 · (512) 324-7000
Beds
240
FY 2025
Star rating
4 of 5
Patient survey: 4 of 5
Net patient revenue
$543.8M
FY 2025
Net income
$14.3M
Patient care margin 1.3%
Discharges
11,109
Occupancy 92.0%
Clinicians
606
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $543.8M | $537.0M | 1.3% | $14.3M | 11,109 | $147.5M | 13.4% | 1.4% |
Official hospital quality measures with the national median across hospitals. For ratios, 1.00 means as many cases as expected.
| Death rate for heart failure patients | 9.7% | US median 11% |
| Hospital-wide death rate within 30 days | 3.2% | US median 3.9% |
| Death rate for pneumonia patients | 14.4% | US median 15.2% |
| Death rate for stroke patients | 10.4% | US median 11.6% |
| Readmission rate for heart failure | 21.8% | US median 21.3% |
| Readmission rate after hip or knee replacement | 5.8% |
Medicare clinicians who list this hospital, by specialty
Inpatient stays by diagnosis related group (DRG), 2024
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
Medicare clinicians who work here
| 2024 | $539.5M | $533.0M | 1.2% | $11.3M | 10,963 | $97.9M | 12.4% | 1.2% |
| 2023 | $438.6M | $457.0M | -4.2% | -$8.9M | 10,322 | $111.7M | 14.8% | 2.6% |
| 2022 | $453.3M | $468.3M | -3.3% | $824K | 10,557 | $110.8M | 14.8% | 3.3% |
| 2021 | $402.5M | $414.1M | -2.9% | -$5.3M | 9,879 | $93.1M | 14.7% | 4.2% |
| 2020 | $424.7M | $427.7M | -0.7% | $16.4M | 11,083 | $111.0M | 16.0% | 4.5% |
| US median 5.8% |
| Readmission rate for pneumonia | 17.3% | US median 17.2% |
| Complications after hip or knee replacement | 3.9% | US median 4.1% |
| Serious complications (patient safety composite) | 0.93 | US median 0.96 |
| C. diff intestinal infections (ratio to expected) | 0.97 | US median 0.28 |
| Central line bloodstream infections (ratio to expected) | 0.63 | US median 0.48 |
| Surgical site infections after colon surgery (ratio to expected) | 0.32 | US median 0.72 |
| MRSA bloodstream infections (ratio to expected) | 0.65 | US median 0.60 |
| Catheter urinary tract infections (ratio to expected) | 0.25 | US median 0.40 · better |
| Doctors always communicated well | 81% | US median 79% |
| Nurses always communicated well | 81% | US median 80% |
| Patient survey summary star rating | 4 of 5 | US median 3 of 5 |
| Area around the room always quiet at night | 65% | US median 59% |
| Patients who rated the hospital 9 or 10 out of 10 | 78% | US median 72% |
| Room and bathroom always clean | 76% | US median 73% |
| Patients who would definitely recommend the hospital | 78% | US median 71% |
| Median time in the emergency department before leaving (minutes) | 249 min | US median 148 min |
| Patients prescribed 2 or more opioids or opioids with benzodiazepines at discharge | 13% | US median 15% |
| Patients who got appropriate care for severe sepsis and septic shock | 42% | US median 65% |
| Healthcare workers given the flu vaccine | 92% | US median 79% |
| 32 |
| $44,281.06 |
| $16,807.19 |
| $7,312.59 |
| DRG 023 CRANIOTOMY WITH MAJOR DEVICE IMPLANT OR ACUTE COMPLEX CNS PRINCIPAL DIAGNOSIS WITH MCC O | 30 | $426,790.97 | $65,916.40 | $47,977.83 |
| DRG 025 CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITH MCC | 26 | $382,542.54 | $51,714.46 | $37,824.45 |
| DRG 481 HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH CC | 24 | $133,537.17 | $26,826.08 | $15,801.33 |
| DRG 470 MAJOR HIP AND KNEE JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MCC | 21 | $238,931.71 | $26,604.90 | $14,289.25 |
| DRG 467 REVISION OF HIP OR KNEE REPLACEMENT WITH CC | 21 | $244,532.52 | $37,953.38 | $26,100.04 |
| DRG 065 INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH CC OR TPA IN 24 HOURS | 20 | $95,723.30 | $17,430.00 | $7,474.08 |
| DRG 086 TRAUMATIC STUPOR AND COMA <1 HOUR WITH CC | 17 | $92,891.29 | $21,095.29 | $10,198.29 |
| DRG 640 MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITH MCC | 17 | $75,051.53 | $21,443.41 | $10,642.23 |
| DRG 872 SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC | 16 | $78,836.44 | $14,641.81 | $7,681.44 |
| DRG 522 HIP REPLACEMENT WITH PRINCIPAL DIAGNOSIS OF HIP FRACTURE WITHOUT MCC | 16 | $172,509.88 | $28,056.06 | $15,768.13 |
| DRG 552 MEDICAL BACK PROBLEMS WITHOUT MCC | 15 | $68,631.47 | $17,949.60 | $7,114.44 |
| DRG 493 LOWER EXTREMITY AND HUMERUS PROCEDURES EXCEPT HIP, FOOT AND FEMUR WITH CC | 14 | $180,528.86 | $30,616.64 | $18,731.31 |
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 8011 Comprehensive Observation Services | 183 | 175 | $1,908.01 | $2,090.36 |
| APC 5362 Level 2 Laparoscopy and Related Services | 76 | 76 | $7,350.56 | $8,164.45 |
| APC 5302 Level 2 Upper GI Procedures | 65 | 58 | $1,336.97 | $1,444.50 |
| APC 5373 Level 3 Urology and Related Services | 46 | 34 | $1,428.35 | $1,516.28 |
| APC 5374 Level 4 Urology and Related Services | 44 | 37 | $2,443.41 | $2,629.24 |
| APC 5375 Level 5 Urology and Related Services | 40 | 36 | $3,498.98 | $3,917.51 |
| APC 5114 Level 4 Musculoskeletal Procedures | 36 | 35 | $5,016.95 | $5,338.75 |
| APC 5073 Level 3 Excision/ Biopsy/ Incision and Drainage | 33 | 33 | $1,945.17 | $2,141.49 |
| APC 5113 Level 3 Musculoskeletal Procedures | 26 | 25 | $2,269.91 | $2,373.24 |
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage | 26 | 26 | $1,136.97 | $1,219.56 |
| APC 5115 Level 5 Musculoskeletal Procedures | 24 | 24 | $9,937.57 | $10,771.69 |
| APC 5191 Level 1 Endovascular Procedures | 20 | 20 | $2,061.75 | $2,207.96 |
Reported payments to this teaching hospital
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Dell Seton Med Center at the University of TX is a nonprofit short-term acute care hospital in Austin, TX with 240 beds, part of Ascension and a 4-star overall rating.
Dell Seton Med Center at the University of TX in Austin, TX has 240 beds (fiscal year 2025 cost report). It discharged 11,109 inpatients that year, with 92.0% of its beds in use on average.
In fiscal year 2025 (ending 2025-06-30), Dell Seton Med Center at the University of TX reported net patient revenue of $543.8M and operating expenses of $537.0M, a margin on patient care of 1.3%. After other income and expenses its net income was $14.3M (2.6% of revenue), so it made a profit that year.
Dell Seton Med Center at the University of TX is part of Ascension, a health system with 58 hospitals based in Indianapolis, IN. It is a nonprofit hospital.
Dell Seton Med Center at the University of TX has an overall rating of 4 out of 5 stars in the official hospital quality ratings. Patients rate it 4 out of 5 stars in the patient survey.
No, Dell Seton Med Center at the University of TX does not list emergency services.
606 Medicare clinicians list Dell Seton Med Center at the University of TX as a hospital they work at, most often in Certified Registered Nurse Anesthetist (Crna), Anesthesiology, Internal Medicine.
In 2024, Dell Seton Med Center at the University of TX had 465 Medicare inpatient stays in 24 diagnosis groups. The most common was DRG 871 (septicemia or severe sepsis without mv >96 hours with mcc) with 50 stays; Medicare paid $28,720.40 per stay on average, compared with $15,524.21 across all hospitals.
In 2025, companies reported $65K in payments to Dell Seton Med Center at the University of TX as a teaching hospital ($3,500 general and $62K for research) from 2 companies.